a Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7369 Matrice Extracellulaire et Dynamique Cellulaire, Université de Reims Champagne-Ardenne, Unité de Formation et de Recherche Sciences Exactes et Naturelles , Reims , France.
b UMR CNRS 7360, LIEC, Université de Lorraine , Metz , France.
Cell Adh Migr. 2017 Jul 4;11(4):316-326. doi: 10.1080/19336918.2016.1215788. Epub 2016 Jul 27.
The low-density lipoprotein receptor-related protein-1 (LRP-1) is a member of Low Density Lipoprotein Receptor (LDLR) family, which is ubiquitously expressed and which is described as a multifunctional endocytic receptor which mediates the clearance of various extracellular matrix molecules including serine proteinases, proteinase-inhibitor complexes, and matricellular proteins. Several studies showed that high LRP-1 expression promotes breast cancer cell invasiveness, and LRP-1 invalidation leads to cell motility abrogation in both tumor and non-tumor cells. Furthermore, our group has reported that LRP-1 silencing prevents the invasion of a follicular thyroid carcinoma despite increased pericellular proteolytic activities from MMP2 and uPA using a 2D-cell culture model. As the use of 3D culture systems is becoming more and more popular due to their promise as enhanced models of tissue physiology, the aim of the present work is to characterize for the first time how the 3D collagen type I matrix may impact the ability of LRP-1 to regulate the migratory properties of thyroid carcinoma using as a model FTC-133 cells. Our results show that inhibition of LRP-1 activity or expression leads to morphological changes affecting cell-matrix interactions, reorganizations of the actin-cytoskeleton especially by inhibiting FAK activation and increasing RhoA activity and MLC-2 phosphorylation, thus preventing cell migration. Taken together, our results suggest that LRP-1 silencing leads to a decrease of cell migratory capacity in a 3D configuration.
低密度脂蛋白受体相关蛋白-1(LRP-1)是 LDLR 家族的成员,在体内广泛表达,是一种多功能的内吞受体,可介导多种细胞外基质分子的清除,包括丝氨酸蛋白酶、蛋白酶抑制剂复合物和基质细胞蛋白。多项研究表明,高 LRP-1 表达可促进乳腺癌细胞的侵袭性,LRP-1 的无效会导致肿瘤和非肿瘤细胞的迁移能力丧失。此外,我们的研究小组曾报道过,LRP-1 沉默可防止滤泡甲状腺癌细胞的侵袭,尽管 MMP2 和 uPA 的细胞周蛋白水解活性增加,但仍能使用二维细胞培养模型实现。由于 3D 培养系统因其作为组织生理学增强模型的潜力而越来越受欢迎,因此本研究的目的是首次描述 3D 胶原 I 基质如何影响 LRP-1 调节甲状腺癌细胞迁移特性的能力,作为模型 FTC-133 细胞。我们的研究结果表明,LRP-1 活性或表达的抑制会导致形态变化,影响细胞与基质的相互作用,细胞骨架的肌动蛋白重排,特别是通过抑制 FAK 激活和增加 RhoA 活性和 MLC-2 磷酸化,从而阻止细胞迁移。总之,我们的研究结果表明,LRP-1 沉默会导致细胞在 3D 结构中的迁移能力下降。